메뉴 건너뛰기




Volumn 476, Issue 1-2, 2003, Pages 159-166

Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats

Author keywords

Antidiabetic agent; Goto Kakizaki rat; Hemoglobin A1c; JTT 608; Nephropathy; Neuropathy

Indexed keywords

4 (4 METHYLCYCLOHEXYL) 4 OXOBUTYRIC ACID; 4 (METHYLCYCLOHEXYL) 4 OXOBUTYRIC ACID; ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

EID: 0142169473     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02120-4     Document Type: Article
Times cited : (10)

References (39)
  • 2
    • 0028232045 scopus 로고
    • Secondary failure of oral hypoglycaemic agents: Frequency, possible causes, and management
    • Antonio E.P., Anna C., Guido P. Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management. Diabetes Metab. Rev. 10:1994;31-43.
    • (1994) Diabetes Metab. Rev. , vol.10 , pp. 31-43
    • Antonio, E.P.1    Anna, C.2    Guido, P.3
  • 3
    • 0020578096 scopus 로고
    • Glibenclamide-associated hypoglycaemia: A report on 57 cases
    • Aspuland K., Wiholm B.E., Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia. 24:1983;412-417.
    • (1983) Diabetologia , vol.24 , pp. 412-417
    • Aspuland, K.1    Wiholm, B.E.2    Lithner, F.3
  • 4
    • 0033578476 scopus 로고    scopus 로고
    • Pharmacologic therapy for type 2 diabetes mellitus
    • Defronzo R.A. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 131:1999;281-303.
    • (1999) Ann. Intern. Med. , vol.131 , pp. 281-303
    • Defronzo, R.A.1
  • 5
    • 0034944773 scopus 로고    scopus 로고
    • The importance of first-phase insulin secretion: Implications for the therapy of type 2 diabetes mellitus
    • Delprato S., Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab. Res. Rev. 17:2001;164-174.
    • (2001) Diabetes Metab. Res. Rev. , vol.17 , pp. 164-174
    • Delprato, S.1    Tiengo, A.2
  • 6
    • 0015962076 scopus 로고
    • An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals
    • Dunber J.C., Foa P.P. An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals. Diabetologia. 10:1974;27-35.
    • (1974) Diabetologia , vol.10 , pp. 27-35
    • Dunber, J.C.1    Foa, P.P.2
  • 7
    • 0023935536 scopus 로고
    • Sulphonylureas and hypoglycaemia
    • Ferner R.E., Neil H.A.W. Sulphonylureas and hypoglycaemia. Br. Med. J. 296:1988;949-950.
    • (1988) Br. Med. J. , vol.296 , pp. 949-950
    • Ferner, R.E.1    Neil, H.A.W.2
  • 8
    • 0032966289 scopus 로고    scopus 로고
    • Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound
    • Furukawa N., Ohta T., Noguchi T., Yonemori F., Wakitani K. Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound. Eur. J. Pharmacol. 371:1999;51-58.
    • (1999) Eur. J. Pharmacol. , vol.371 , pp. 51-58
    • Furukawa, N.1    Ohta, T.2    Noguchi, T.3    Yonemori, F.4    Wakitani, K.5
  • 9
    • 0024465303 scopus 로고
    • Oral hypoglycemic agents
    • Gerich J.E. Oral hypoglycemic agents. N. Engl. J. Med. 321:1989;1231-1245.
    • (1989) N. Engl. J. Med. , vol.321 , pp. 1231-1245
    • Gerich, J.E.1
  • 11
    • 0026659006 scopus 로고
    • Sulfonylureas in NIDDM
    • Groop L.C. Sulfonylureas in NIDDM. Diabetes Care. 15:1992;737-754.
    • (1992) Diabetes Care , vol.15 , pp. 737-754
    • Groop, L.C.1
  • 12
    • 0027942327 scopus 로고
    • Comparison of efficacy, secondary failure rate, and complications of sulfonylureas
    • Harrower A.D.B. Comparison of efficacy, secondary failure rate, and complications of sulfonylureas. J. Diabetes its Complicat. 8:1994;201-203.
    • (1994) J. Diabetes its Complicat. , vol.8 , pp. 201-203
    • Harrower, A.D.B.1
  • 13
    • 0033291452 scopus 로고    scopus 로고
    • La régulation du glucose prandial est-elle importante dans le diabéte de type 2?
    • Home P. La régulation du glucose prandial est-elle importante dans le diabéte de type 2? Diabetes Metab. (Suppl. 7):1999;20-21.
    • (1999) Diabetes Metab. , Issue.SUPPL. 7 , pp. 20-21
    • Home, P.1
  • 15
    • 0025904306 scopus 로고
    • Comparison of B-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin- induced non-insulin-dependent diabetic rats
    • Kawai K., Suzuki S., Murayama Y., Watanabe Y., Yamashita K. Comparison of B-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin- dependent diabetic rats. Diabetes Res. Clin. Pract. 12:1991;163-172.
    • (1991) Diabetes Res. Clin. Pract. , vol.12 , pp. 163-172
    • Kawai, K.1    Suzuki, S.2    Murayama, Y.3    Watanabe, Y.4    Yamashita, K.5
  • 16
    • 0027984443 scopus 로고
    • Insulin secretory response in Japanese type 2 (non-insulin-dependent) diabetic patients
    • Kosaka K., Kuzuya T., Hagura R. Insulin secretory response in Japanese type 2 (non-insulin-dependent) diabetic patients. Diabetes Res. Clin. Pract. 24:1994;S101-S110.
    • (1994) Diabetes Res. Clin. Pract. , vol.24
    • Kosaka, K.1    Kuzuya, T.2    Hagura, R.3
  • 17
    • 0036617088 scopus 로고    scopus 로고
    • The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent
    • Lam N.T., Kieffer T.J. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent. Minerva Endocrinol. 27:2002;79-93.
    • (2002) Minerva Endocrinol. , vol.27 , pp. 79-93
    • Lam, N.T.1    Kieffer, T.J.2
  • 18
    • 0032850854 scopus 로고    scopus 로고
    • Approaches to the management of postprandial hyperglycaemia
    • Landgraf R. Approaches to the management of postprandial hyperglycaemia. Exp. Clin. Endocrinol. Diabetes. 107(Suppl. 4):1999;S128-S132.
    • (1999) Exp. Clin. Endocrinol. Diabetes , vol.107 , Issue.SUPPL. 4
    • Landgraf, R.1
  • 19
    • 0035283412 scopus 로고    scopus 로고
    • The significance of postprandial glycemia
    • Lehmann R. The significance of postprandial glycemia. Schweiz. Rundsch. Med. PRAXIS. 90:2001;345-348.
    • (2001) Schweiz. Rundsch. Med. PRAXIS , vol.90 , pp. 345-348
    • Lehmann, R.1
  • 20
    • 0029916829 scopus 로고    scopus 로고
    • Sulphonylurea treatment of NIDDM patients with cardiovascular diseases: A mixed blessing?
    • Leibowitz G., Cerasl E. Sulphonylurea treatment of NIDDM patients with cardiovascular diseases: a mixed blessing? Diabetologia. 39:1996;503-514.
    • (1996) Diabetologia , vol.39 , pp. 503-514
    • Leibowitz, G.1    Cerasl, E.2
  • 21
    • 0015903562 scopus 로고
    • Serial in vivo determinations of nerve conduction velocity in rat tails: Physiological and pathological changes
    • Miyoshi T., Goto I. Serial in vivo determinations of nerve conduction velocity in rat tails: physiological and pathological changes. Electroencephalogr. Clin. Neurophysiol. 35:1973;125-131.
    • (1973) Electroencephalogr. Clin. Neurophysiol. , vol.35 , pp. 125-131
    • Miyoshi, T.1    Goto, I.2
  • 22
    • 0030814657 scopus 로고    scopus 로고
    • Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat
    • Movassat J., Saulnier C., Serradas P., Portha B. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat. Diabetologia. 40:1997;916-925.
    • (1997) Diabetologia , vol.40 , pp. 916-925
    • Movassat, J.1    Saulnier, C.2    Serradas, P.3    Portha, B.4
  • 24
    • 0033042904 scopus 로고    scopus 로고
    • JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats
    • Ohta T., Furukawa N., Yonemori F., Wakitani K. JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats. Eur. J. Pharmacol. 367:1999;91-99.
    • (1999) Eur. J. Pharmacol. , vol.367 , pp. 91-99
    • Ohta, T.1    Furukawa, N.2    Yonemori, F.3    Wakitani, K.4
  • 25
    • 0032907568 scopus 로고    scopus 로고
    • JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats
    • Ohta T., Furukawa N., Komuro G., Yonemori F., Wakitani K. JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats. Br. J. Pharmacol. 126:1999;1674-1680.
    • (1999) Br. J. Pharmacol. , vol.126 , pp. 1674-1680
    • Ohta, T.1    Furukawa, N.2    Komuro, G.3    Yonemori, F.4    Wakitani, K.5
  • 27
    • 0034109448 scopus 로고    scopus 로고
    • Effect of peroxisome prolifertor-activated receptor-α and -γ agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats
    • Shibata T., Takeuchi S., Yokota S., Kakimoto K., Yonemori F., Wakitani K. Effect of peroxisome prolifertor-activated receptor-α and -γ agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br. J. Pharmacol. 130:2000;495-504.
    • (2000) Br. J. Pharmacol. , vol.130 , pp. 495-504
    • Shibata, T.1    Takeuchi, S.2    Yokota, S.3    Kakimoto, K.4    Yonemori, F.5    Wakitani, K.6
  • 28
    • 0032585591 scopus 로고    scopus 로고
    • 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent
    • Shinkai H., Ozeki H., Motomura T., Ohta T., Furukawa N., Uchida I. 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent. J. Med. Chem. 41:1998;5420-5428.
    • (1998) J. Med. Chem. , vol.41 , pp. 5420-5428
    • Shinkai, H.1    Ozeki, H.2    Motomura, T.3    Ohta, T.4    Furukawa, N.5    Uchida, I.6
  • 29
    • 0014850220 scopus 로고
    • Reduction in the activity of the pancreatic islets induced in normal rodents by prolonged treatment with derivatives of sulfonylurea
    • Sodoyers J.C., Sodoyers-Goffaux F., Dunbar J.C., Foa P.P. Reduction in the activity of the pancreatic islets induced in normal rodents by prolonged treatment with derivatives of sulfonylurea. Diabetes. 19:1970;603-609.
    • (1970) Diabetes , vol.19 , pp. 603-609
    • Sodoyers, J.C.1    Sodoyers-Goffaux, F.2    Dunbar, J.C.3    Foa, P.P.4
  • 30
    • 0030803023 scopus 로고    scopus 로고
    • Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes
    • Sone H., Kawakami Y., Okuda Y., Sekine Y., Honmura S., Matsuo K., Segawa T., Suzuki H., Yamashita K. Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia. 40:1997;726-730.
    • (1997) Diabetologia , vol.40 , pp. 726-730
    • Sone, H.1    Kawakami, Y.2    Okuda, Y.3    Sekine, Y.4    Honmura, S.5    Matsuo, K.6    Segawa, T.7    Suzuki, H.8    Yamashita, K.9
  • 31
    • 0023212133 scopus 로고
    • Effect of gangliosides on nerve conduction velocity during diabetic neuropathy in the rat
    • Spüler M., Dimpfel W., Tüller H.U. Effect of gangliosides on nerve conduction velocity during diabetic neuropathy in the rat. Arch. Int. Pharmacodyn. Ther. 287:1987;211-223.
    • (1987) Arch. Int. Pharmacodyn. Ther. , vol.287 , pp. 211-223
    • Spüler, M.1    Dimpfel, W.2    Tüller, H.U.3
  • 32
  • 33
    • 0031729818 scopus 로고    scopus 로고
    • The U.K. Prospective diabetes study. a review
    • Turner R.C. The U.K. Prospective diabetes study. a review. Diabetes Care. (Suppl. 3):1998;35-38.
    • (1998) Diabetes Care , Issue.SUPPL. 3 , pp. 35-38
    • Turner, R.C.1
  • 34
    • 0032983666 scopus 로고    scopus 로고
    • Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group
    • Turner R.C., Cull C.A., Frighi V., Holman R.R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 281:1999;2005-2012.
    • (1999) JAMA , vol.281 , pp. 2005-2012
    • Turner, R.C.1    Cull, C.A.2    Frighi, V.3    Holman, R.R.4
  • 35
  • 36
    • 0032693929 scopus 로고    scopus 로고
    • Effects of long-term treatment with alpha-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: A genetic model for type 2 diabetes
    • Wada R., Koyama M., Mizushima H., Okada H., Ikeda H., Yagihashi S. Effects of long-term treatment with alpha-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: a genetic model for type 2 diabetes. Diabetes Metab. Res. Rev. 15:1999;332-337.
    • (1999) Diabetes Metab. Res. Rev. , vol.15 , pp. 332-337
    • Wada, R.1    Koyama, M.2    Mizushima, H.3    Okada, H.4    Ikeda, H.5    Yagihashi, S.6
  • 37
    • 0015413087 scopus 로고
    • Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels
    • William C.D., Solomon S.S., Abbas E.K. Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels. J. Clin. Endocrinol. Metab. 35:1972;585-591.
    • (1972) J. Clin. Endocrinol. Metab. , vol.35 , pp. 585-591
    • William, C.D.1    Solomon, S.S.2    Abbas, E.K.3
  • 38
    • 0018223556 scopus 로고
    • Thickening of glomerular basement membrane in spontaneously diabetic rats
    • Yagihashi S., Goto Y., Kakizaki M., Kaseda N. Thickening of glomerular basement membrane in spontaneously diabetic rats. Diabetologia. 15:1978;309-312.
    • (1978) Diabetologia , vol.15 , pp. 309-312
    • Yagihashi, S.1    Goto, Y.2    Kakizaki, M.3    Kaseda, N.4
  • 39
    • 0020468270 scopus 로고
    • Peripheral neuropathy in selectively-inbred spontaneously diabetic rats: Electrophysiological, morphometrical and freeze-replica studies
    • Yagihashi S., Tonosaki A., Yamada K., Kakiaki M., Goto Y. Peripheral neuropathy in selectively-inbred spontaneously diabetic rats: electrophysiological, morphometrical and freeze-replica studies. Tohoku J. Exp. Med. 138:1982;39-48.
    • (1982) Tohoku J. Exp. Med. , vol.138 , pp. 39-48
    • Yagihashi, S.1    Tonosaki, A.2    Yamada, K.3    Kakiaki, M.4    Goto, Y.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.